NU507 Letter to the Senator

NU507 Letter to the Senator

Student Name

Purdue University Global

NU507 Promoting Optimal Models and Systems for Health Care Delivery

Prof. Name:

Date

NU507 Letter to the Senator

Healthcare workers need evidence-based quarantine and testing policies that protect both medical professionals and patients while ensuring healthcare systems remain fully operational. Expanding employer-funded PCR testing after workplace exposure to communicable diseases, including COVID-19, can improve early detection, reduce workplace transmission, support informed return-to-work decisions, and strengthen public health preparedness. The following letter advocates for policy improvements that prioritize healthcare worker safety while maintaining quality patient care.

Letter to the Senator

May 31, ____

The Honorable Ted Cruz
Texas State Senator
300 East 8th Street, Suite 961
Austin, Texas 78701

Dear Senator Cruz,

My name is ________, BSN, RN, and I am a registered nurse with ten years of clinical experience. I am currently pursuing graduate studies at Purdue University Global to become an Advanced Practice Registered Nurse (APRN) specializing in Family Practice Nursing. I am writing to encourage legislative support for stronger healthcare policies regarding quarantine requirements and testing procedures for healthcare professionals who are exposed to communicable diseases, including COVID-19.

The COVID-19 pandemic demonstrated both the indispensable role of healthcare workers and the vulnerabilities they face when caring for patients with infectious illnesses. Nurses, physicians, and other frontline professionals routinely encounter elevated exposure risks while providing essential medical care. As scientific evidence continues to evolve, workplace policies should also advance to better protect healthcare personnel without compromising healthcare system capacity.

Throughout the pandemic, the Centers for Disease Control and Prevention (CDC) updated its recommendations based on vaccination status, emerging variants, testing availability, and growing scientific knowledge. Guidance regarding quarantine, masking, and return-to-work procedures evolved to balance infection prevention with the need to maintain an adequate healthcare workforce (Centers for Disease Control and Prevention [CDC], 2021). Despite these adjustments, many healthcare professionals remained concerned about workplace exposure, delayed symptom onset, and the possibility of transmitting infections to vulnerable patients.

As an emergency room nurse with a decade of clinical experience, I have witnessed the physical, emotional, and professional challenges healthcare workers endured during the COVID-19 crisis. Staffing shortages, extended work hours, emotional fatigue, and burnout became common across healthcare settings. Returning healthcare professionals to patient care shortly after workplace exposure without consistent access to timely diagnostic testing often increased anxiety and uncertainty, particularly because individuals may remain asymptomatic during the early stages of infection.

One practical policy improvement would be expanding employer-funded Polymerase Chain Reaction (PCR) testing following documented workplace exposure. PCR testing remains one of the most accurate diagnostic methods for detecting SARS-CoV-2 infection and supports earlier identification of infected healthcare workers (CDC, 2020). Increased testing availability would enable healthcare organizations to make evidence-based decisions regarding isolation requirements, return-to-work timelines, staffing management, and infection control strategies.

Although implementing expanded PCR testing programs would require additional financial investment, many healthcare organizations already possess laboratory infrastructure capable of supporting increased testing capacity. The primary costs would involve testing supplies, laboratory personnel, and operational resources. However, these expenditures may be offset by preventing workplace outbreaks, reducing employee illness, minimizing staffing shortages, and avoiding unnecessary compensation costs for employees who test negative and can safely return to work.

Healthcare organizations should also recognize that supporting frontline professionals extends beyond infection prevention. Policies that prioritize employee health, workplace safety, and access to reliable diagnostic resources foster trust between healthcare workers and organizational leadership. When nurses feel protected and valued, they are more likely to remain engaged, resilient, and committed to delivering safe, high-quality patient care.

Nurses are uniquely qualified to contribute to healthcare policy development because they experience firsthand how regulations affect patient outcomes, workplace safety, and clinical operations. Advanced Practice Registered Nurses (APRNs) and other nursing professionals can provide valuable clinical insight when shaping policies related to infectious disease prevention, occupational health, emergency preparedness, and healthcare workforce sustainability.

Protecting healthcare workers must remain a central component of future public health planning. Evidence-based policies that support accessible testing, appropriate staffing levels, and effective infection prevention strategies will strengthen healthcare systems while improving preparedness for future public health emergencies.

Thank you, Senator Cruz, for considering this important healthcare issue. I appreciate your continued commitment to protecting the health and well-being of Texans and respectfully encourage your support for policies that enhance workplace safety for healthcare professionals across our state.

Respectfully,

Student Name

Key Policy Recommendations

The proposed healthcare policy focuses on strengthening occupational safety through practical, evidence-based measures, including:

• Expand employer-funded PCR testing after workplace exposure.

• Use evidence-based return-to-work protocols.

• Strengthen infection prevention strategies.

• Improve healthcare workforce protection.

• Reduce workplace transmission of communicable diseases.

• Support nurse well-being through safer workplace policies.

• Maintain adequate staffing while protecting patient safety.

Quick Facts

• Healthcare workers face higher occupational exposure to infectious diseases than the general population.

• PCR testing remains one of the most reliable methods for detecting SARS-CoV-2 infection.

• Evidence-based testing policies improve workplace safety and support informed return-to-work decisions.

• Strong occupational health policies help reduce healthcare-associated infections and workforce shortages.

• Nurses play a vital role in developing healthcare policies because of their frontline clinical expertise.

Frequently Asked Questions (FAQs)

Why should healthcare workers receive employer-funded PCR testing after workplace exposure?

Employer-funded PCR testing allows healthcare organizations to identify infections early, reduce workplace transmission, and make evidence-based decisions regarding isolation and return-to-work timelines.

Why are evidence-based quarantine policies important?

Evidence-based quarantine policies protect healthcare workers and patients while helping healthcare facilities maintain safe staffing levels during infectious disease outbreaks.

What role do nurses play in healthcare policymaking?

Nurses provide firsthand clinical experience that helps policymakers develop practical regulations related to infection prevention, occupational safety, emergency preparedness, and patient care.

How does expanded testing benefit healthcare organizations?

Expanded testing reduces the risk of workplace outbreaks, supports workforce stability, minimizes unnecessary employee absences, and improves infection control efforts.

Why is protecting healthcare workers considered a public health priority?

Healthcare workers are essential to maintaining healthcare services during emergencies. Protecting their health improves patient safety, preserves healthcare capacity, and strengthens public health preparedness.

References

Centers for Disease Control and Prevention. (2020). Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19. https://www.cdc.gov/covid/hcp/clinical-care/clinical-specimen-guidelines.html

NU507 Letter to the Senator

Centers for Disease Control and Prevention. (2021). Interim guidance for managing healthcare personnel with SARS-CoV-2 infection or exposure to SARS-CoV-2. https://www.cdc.gov/covid/hcp/infection-control/guidance-risk-assesment-hcp.html